Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra Treatment of Recurrent Idiopathic Pericarditis
2013-001849-13Phase 3Completed
- Sponsor
- Maria Vittoria Hospital Cardiology
- Start
- Oct 2016
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in idiopathic recurrent pericarditis (IRP) comparing Anakinra continuation arm with Placebo withdrawal arm (2 arms). Primary endpoint: Time to flare in withdrawal phase. Started Oct 2016; status: completed.
02
Drugs
anakinra
03
Conditions
idiopathic recurrent pericarditis (IRP)
Beyond the preview
Go deeper on 2013-001849-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001849-13.